Srinivasan Dasarathy

12PUBLICATIONS
33CO-AUTHORS
Industrial molecular engineering of nucleic acids and proteinsOccupational epidemiologyMolecular targetsInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 25, 2024
Ammonia transporter RhBG initiates downstream signaling and functional responses by activating NFκB.

Saurabh Mishra, Nicole Welch, Shashi Shekhar Singh

|Apr 10, 2023
STAT2 hinders STING intracellular trafficking and reshapes its activation in response to DNA damage.

Chenyao Wang, Jing Nan, Elise Holvey-Bates

|Jan 03, 2023
Type I interferon signaling facilitates resolution of acute liver injury by priming macrophage polarization.

Qiaoling Song, Shyamasree Datta, Xue Liang

|May 18, 2022
H3K9 methylation drives resistance to androgen receptor-antagonist therapy in prostate cancer.

Mehdi Baratchian, Ritika Tiwari, Sirvan Khalighi

|Nov 20, 2021
PD-L1 sustains chronic, cancer cell-intrinsic responses to type I interferon, enhancing resistance to DNA damage.

HyeonJoo Cheon, Elise G Holvey-Bates, Daniel J McGrail

Pageof 2